Aclaris Therapeutics Announces Exclusive Patent License Agreement With Sun Pharma For Rights Of Deuruxolitinib; Agreement Includes Upfront Payment Of $15M Plus Milestones And Royalties
Aclaris Therapeutics Announces Exclusive Patent License Agreement With Sun Pharma For Rights Of Deuruxolitinib; Agreement Includes Upfront Payment Of $15M Plus Milestones And Royalties
Aclaris Therapeutics宣佈與Sun Pharma就Deuruxolitinib的權利達成獨家專利許可協議;協議包括1500萬美元的預付款,外加里程碑和特許權使用費
Aclaris Therapeutics Announces Exclusive Patent License Agreement With Sun Pharma For Rights Of Deuruxolitinib; Agreement Includes Upfront Payment Of $15M Plus Milestones And Royalties
Aclaris Therapeutics宣佈與Sun Pharma就Deuruxolitinib的權利達成獨家專利許可協議;協議包括1500萬美元的預付款,外加里程碑和特許權使用費